| Marina Mudd Sprague, | |
|
206 Alaska Frontage Rd, Belgrade, MT 59714-7909 | |
| (406) 414-3334 | |
| Not Available |
| Full Name | Marina Mudd Sprague |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 206 Alaska Frontage Rd, Belgrade, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780144469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MED-PHYS-LIC-127105 (Montana) | Primary |
| Entity Name | Bozeman Health Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619347390 PECOS PAC ID: 4688984164 Enrollment ID: O20151112002559 |
News Archive
Spanish and US scientists have successfully identified animal species that can transmit more diseases to humans by using mathematical tools similar to those applied to the study of social networks like Facebook or Twitter.
The international community "needs an approach that focuses not on fostering democratic governance" in Myanmar "but on the critical health and education needs," including curbing the spread of HIV, among the country's "long suffering" population.
The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
Amphora Discovery Corporation, a small molecule drug discovery company, announced today that it has entered into an agreement with Genentech, Inc. pursuant to which Genentech will purchase Amphora's entire program for an unnamed oncology target with the potential to treat multiple oncology indications.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marina Mudd Sprague, 206 Alaska Frontage Rd, Belgrade, MT 59714-7909 Ph: (406) 414-3334 | Marina Mudd Sprague, 206 Alaska Frontage Rd, Belgrade, MT 59714-7909 Ph: (406) 414-3334 |
News Archive
Spanish and US scientists have successfully identified animal species that can transmit more diseases to humans by using mathematical tools similar to those applied to the study of social networks like Facebook or Twitter.
The international community "needs an approach that focuses not on fostering democratic governance" in Myanmar "but on the critical health and education needs," including curbing the spread of HIV, among the country's "long suffering" population.
The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
Amphora Discovery Corporation, a small molecule drug discovery company, announced today that it has entered into an agreement with Genentech, Inc. pursuant to which Genentech will purchase Amphora's entire program for an unnamed oncology target with the potential to treat multiple oncology indications.
› Verified 5 days ago
Philip A Bain, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 Alaska Frontage Rd, Belgrade, MT 59714 Phone: 406-414-3334 | |
David Stern, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 403 W Main St, Belgrade, MT 59714 Phone: 406-388-8708 Fax: 406-388-8710 |